← Back to Search

Behavioural Intervention

CranioSacral Therapy for Parkinson's Disease

N/A
Waitlist Available
Led By Al Raza, CST
Research Sponsored by Zia, Al Raza
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with Parkinson's Disease
Be older than 18 years old
Must not have
Anyone without Parkinson's Disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying the effect of CranioSacral Integrative therapy on Parkinson's Diseased Patients. This therapy is given biweekly for 3 months, and the investigators expect to see a positive change in the symptoms of the patients.

Who is the study for?
This trial is for individuals who have been diagnosed with Parkinson's Disease. It aims to include those specifically suffering from this condition and excludes anyone who does not have Parkinson's Disease.
What is being tested?
The study is testing the effects of CranioSacral Integrative Therapy on patients with Parkinson's Disease over a period of 3 months, involving biweekly therapy sessions lasting 90 minutes each.
What are the potential side effects?
Since CranioSacral Integrative Therapy is a manual therapeutic approach, potential side effects may include discomfort or mild pain during or after treatment, headache, fatigue, or emotional release.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Parkinson's Disease.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have Parkinson's Disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
reduction in tremors due to Parkinson's disease in the patient
Secondary study objectives
Quality of Proprioception
Other study objectives
Overall emotional State and sleep quality

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: biweekly interventionExperimental Treatment1 Intervention
biweekly intervention

Find a Location

Who is running the clinical trial?

Zia, Al RazaLead Sponsor
Al Raza, CSTPrincipal InvestigatorIBR, Inc.

Media Library

Biweekly Intervention (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT01989013 — N/A
Parkinson's Disease Research Study Groups: biweekly intervention
Parkinson's Disease Clinical Trial 2023: Biweekly Intervention Highlights & Side Effects. Trial Name: NCT01989013 — N/A
Biweekly Intervention (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01989013 — N/A
~0 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top